Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
-329.86x11.84x6.74x27.4x1508.36x-330.88x-.--% 1.35TCr
43.19x6.77x2.1x10.11x36.48x37.2x0.03% 4.56TCr
16.15x3.9x0.21x5.76x12.69x13.87x1.85% 4.08TCr
-53.49x93.4x0.92x18.02x-59.54x-58.71x-.--% 3.1TCr
-16.58x1x2.2x2.76x-13.85x-4.56x-.--% 2.11TCr
28.08x2.75x0.6x5.79x16.09x19.89x-.--% 1.94TCr
22.45x2.64x-1.25x4.26x13.93x15.83x-.--% 1.71TCr
-14.37x62.88x0.69x6424.77x-18.36x-13.86x-.--% 1.27TCr
-172.74x19.08x-2.01x42.14x-167.37x-152.68x-.--% 1.23TCr
13.5x3.48x1.35x3.75x8.9x10.01x-.--% 1.07TCr
-85.77x16.43x1.41x6.32x-94.47x-65.2x-.--% 992.8Cr
-29.13x - 1.05x - - - - 823.52Cr
-7.89x - -0.25x - -6.99x-6.78x-.--% 838.19Cr
-17.13x15.42x-0x16.51x-23.48x-16.54x-.--% 828.99Cr
-17.99x6.12x6.34x509.09x-15.71x-15.87x-.--% 803.94Cr
33.47x6.36x0.71x9.68x24.41x25.12x0.25% 783.19Cr
-216.42x17.05x2.5x20.06x357.18x-454.91x-.--% 841.97Cr
-9.95x-31.86x7.38x80.07x-10.77x-10.36x-.--% 790.71Cr
Average -45.25x 14.83x 1.70x 449.16x 92.21x -59.32x 0.13% 1.62TCr
Weighted average by Cap. -28.05x 18.19x 1.43x 323.91x 72.83x -35.74x 0.28%
Bio Therapeutic Drugs
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW